Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels

Lina Sabor; Mélanie Raphaël; Jean-Michel Dogné; François Mullier; Jonathan Douxfils

doi:10.1016/j.thromres.2017.05.024

Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels

Lina Sabor, Mélanie Raphaël, Jean-Michel Dogné, François Mullier, Jonathan Douxfils

Résultats de recherche: Contribution à un journal/une revue › Article › Revue par des pairs

langue originale	Anglais
Pages (de - à)	36-38
Nombre de pages	3
journal	Thrombosis Research
Volume	156
Date de mise en ligne précoce	2017
Les DOIs	https://doi.org/10.1016/j.thromres.2017.05.024
Etat de la publication	Publié - 1 août 2017

Accès au document

10.1016/j.thromres.2017.05.024

Autres fichiers et liens

Link to publication in Scopus

Contient cette citation

@article{be02a5482cb84fad959364bf3e291736,

title = "Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels",

keywords = "Apixaban, Chromogenic anti-Xa assays, Edoxaban, Heparin, Rivaroxaban, Heparin/pharmacology, Humans, Blood Coagulation Tests/methods, Factor Xa Inhibitors/therapeutic use, Anticoagulants/therapeutic use",

author = "Lina Sabor and M{\'e}lanie Rapha{\"e}l and Jean-Michel Dogn{\'e} and Fran{\c c}ois Mullier and Jonathan Douxfils",

year = "2017",

month = aug,

day = "1",

doi = "10.1016/j.thromres.2017.05.024",

language = "English",

volume = "156",

pages = "36--38",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier",

}

TY - JOUR

T1 - Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels

AU - Sabor, Lina

AU - Raphaël, Mélanie

AU - Dogné, Jean-Michel

AU - Mullier, François

AU - Douxfils, Jonathan

PY - 2017/8/1

Y1 - 2017/8/1

KW - Apixaban

KW - Chromogenic anti-Xa assays

KW - Edoxaban

KW - Heparin

KW - Rivaroxaban

KW - Heparin/pharmacology

KW - Humans

KW - Blood Coagulation Tests/methods

KW - Factor Xa Inhibitors/therapeutic use

KW - Anticoagulants/therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=85019984647&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2017.05.024

DO - 10.1016/j.thromres.2017.05.024

M3 - Article

C2 - 28582639

SN - 0049-3848

VL - 156

SP - 36

EP - 38

JO - Thrombosis Research

JF - Thrombosis Research

ER -